Showing entries for:
METAvivor Research and Support announces 27 new grant awards for metastatic breast cancer research totaling $5.75 million. METAvivor held its annual metastatic breast cancer research cycle in 2022 and as a result of strong support from generous donors Metavivor is able to announce another banner year for peer-reviewed, metastatic breast cancer research funding.
